发布求助
文献互助 智能选刊 最新文献

Progress in neurological surgery最新文献

筛选
英文 中文
Functional Anatomy of Basal Ganglia Circuits with the Cerebral Cortex and the Cerebellum. 基底神经节回路与大脑皮层和小脑的功能解剖。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2018-01-12 DOI: 10.1159/000480748
Andreea C Bostan, Richard P Dum, Peter L Strick
{"title":"Functional Anatomy of Basal Ganglia Circuits with the Cerebral Cortex and the Cerebellum.","authors":"Andreea C Bostan,&nbsp;Richard P Dum,&nbsp;Peter L Strick","doi":"10.1159/000480748","DOIUrl":"https://doi.org/10.1159/000480748","url":null,"abstract":"<p><p>The neural connections of the basal ganglia provide important insights into their function. Here, we discuss the current perspective on basal ganglia connections with the cerebral cortex and with the cerebellum. We review the evidence that the basal ganglia participate in functionally segregated circuits with motor and non-motor areas of the cerebral cortex. We then discuss the data that the basal ganglia are interconnected with the cerebellum. These results provide the anatomical substrate for basal ganglia contributions not only to the control of movement, but also to a variety of cognitive and affective functions. Furthermore, these findings indicate that abnormal activity in basal ganglia circuits with the cerebral cortex and with the cerebellum may contribute to both motor and non-motor deficits associated with several neurologic and psychiatric conditions.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000480748","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35735740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 52
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Treating Movement Disorders. 磁共振引导的高强度聚焦超声治疗运动障碍。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2018-01-12 DOI: 10.1159/000481080
Young Goo Kim, Eun Jung Kweon, Won Seok Chang, Hyun Ho Jung, Jin Woo Chang
{"title":"Magnetic Resonance-Guided High Intensity Focused Ultrasound for Treating Movement Disorders.","authors":"Young Goo Kim,&nbsp;Eun Jung Kweon,&nbsp;Won Seok Chang,&nbsp;Hyun Ho Jung,&nbsp;Jin Woo Chang","doi":"10.1159/000481080","DOIUrl":"https://doi.org/10.1159/000481080","url":null,"abstract":"<p><p>Transcranial magnetic resonance-guided focused ultrasound (MRgFUS) surgery has recently gained favor as a novel, noninvasive alternative to conventional neurosurgery. In contrast to traditional ablative interventions, transcranial MRgFUS surgery is entirely imaging-guided and uses continuous temperature measurements at the target and surrounding tissue taken in real-time. Unlike Gamma Knife radiosurgery, MRgFUS surgery can make a lesion immediately and does not use ionizing radiation. Moreover, since no metallic device is implanted, MR imaging-based diagnosis is not restricted throughout life. An additional strength of transcranial MRgFUS surgery is its ability to focus acoustic energy through the intact skull onto deep-seated targets, while minimizing adjacent tissue damage. Even though the established indications of MRgFUS include bone metastases, uterine fibroids, and breast lesions, several promising preclinical and phase I clinical trials of neuropathic pain, essential tremor, Parkinson's disease (PD), and obsessive-compulsive disorder have demonstrated that the delivery of focused ultrasound energy promises to be a broadly applicable technique. For instance, this technique can be used to generate focal intracranial thermal ablative lesions of brain tumors, or to silence dysfunctional neural circuits and disrupt the blood-brain barrier for targeted drug delivery and the modulation of neural activity. Here we review the general principles of MRgFUS and its current applications, with a special focus on movement disorders such as essential tremor and PD, and discuss controversies and limitations of this technique.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000481080","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35735745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Cell-Based Immunotherapy of Gliomas. 神经胶质瘤的细胞免疫治疗。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2018-07-10 DOI: 10.1159/000469683
Richard G Everson, Joseph P Antonios, Linda M Liau
{"title":"Cell-Based Immunotherapy of Gliomas.","authors":"Richard G Everson,&nbsp;Joseph P Antonios,&nbsp;Linda M Liau","doi":"10.1159/000469683","DOIUrl":"https://doi.org/10.1159/000469683","url":null,"abstract":"<p><p>Current cell-based immunotherapeutic strategies attempt to produce and maintain an immune response against glioma cells by artificially stimulating the immune system using passive and/or active approaches. Cellular immunotherapy is taken to mean the administration of live immune cells that either have immune effector capabilities themselves (passive immunotherapy) or engender a downstream antitumor response (active immunotherapy). Passive cellular immunotherapy most often takes the form of the adoptive transfer of a range of cell types, whereby antitumor immune cells from a patient (or allogeneic donor) are created, activated, and/or expanded ex vivo and subsequently administered back to the patient to directly attack the neoplasm. Active cellular immunotherapy approaches for the treatment of malignant gliomas have most often taken the form of dendritic cell (DC)-based vaccines.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000469683","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36299197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Search for More Effective Chemotherapeutic Regimens for Gliomas: Challenges and Hopes. 寻找更有效的胶质瘤化疗方案:挑战与希望。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2018-01-25 DOI: 10.1159/000467380
Jethro Hu, Santosh Kesari
{"title":"Search for More Effective Chemotherapeutic Regimens for Gliomas: Challenges and Hopes.","authors":"Jethro Hu,&nbsp;Santosh Kesari","doi":"10.1159/000467380","DOIUrl":"https://doi.org/10.1159/000467380","url":null,"abstract":"<p><p>Are truly effective therapies for glioma finally within reach? An explosion of technologies and treatments in recent years brings with it the hope that the revolution is nigh, but decades of gains that can at best be considered incremental understandably temper optimism. Concepts such as \"targeted therapy\" and \"personalized medicine\" have grabbed the attention of the oncology community for over a decade; yet when applied to glioblastoma, our initial efforts have amounted to running into battle with limited armaments and an incomplete understanding of the enemy. Still, there is reason to believe that recent insights and advances have changed the equation, with real gains just over the horizon.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000467380","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35787739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Perspectives of Nanotechnology in the Management of Gliomas. 纳米技术在神经胶质瘤治疗中的应用前景。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2018-07-10 DOI: 10.1159/000469691
Jang W Yoon, Wen Jiang, James T Rutka, Yuhui Huang, Betty Y S Kim
{"title":"Perspectives of Nanotechnology in the Management of Gliomas.","authors":"Jang W Yoon,&nbsp;Wen Jiang,&nbsp;James T Rutka,&nbsp;Yuhui Huang,&nbsp;Betty Y S Kim","doi":"10.1159/000469691","DOIUrl":"https://doi.org/10.1159/000469691","url":null,"abstract":"<p><p>Significant advances in the design and understanding of the materials and systems of 1-100 nm have provided unprecedented tools to probe, diagnose, and treat diseases at the molecular level with greater efficiency and accuracy. In particular, optical and chemical properties of nanomaterials are being exploited to improve the effectiveness of neuro-oncological and neurosurgical interventions. Modern nanotechnology-driven clinical applications may have significant impact on management of brain tumors.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000469691","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36298612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Brachytherapy of Intracranial Gliomas. 颅内胶质瘤的近距离放疗。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2018-01-25 DOI: 10.1159/000467114
Silke Birgit Nachbichler, Friedrich-Wilhelm Kreth
{"title":"Brachytherapy of Intracranial Gliomas.","authors":"Silke Birgit Nachbichler,&nbsp;Friedrich-Wilhelm Kreth","doi":"10.1159/000467114","DOIUrl":"https://doi.org/10.1159/000467114","url":null,"abstract":"<p><p>Interstitial implantation of radioactive materials (brachytherapy [BT]) has been designed to protractedly deliver a high radiation dose to a well-defined target volume, while minimizing irradiation of the adjacent normal tissues. Even though promising results have been reported over time, the role of this treatment modality in the management of brain tumors is still poorly defined, and only a few centers worldwide apply it in clinical practice. Nevertheless, temporary or permanent interstitial implantation of low activity (<20 mCi) and low dose rate (≤10 cGy/h) iodine-125 (125I) seeds as possible therapy of intracranial gliomas is currently undergoing a definite revival, and several indications for its use have been identified. Generally, 125I-BT may be considered a reasonable option in cases of unresectable, well-circumscribed, either newly diagnosed or recurrent tumors with a diameter of ≤4 cm, virtually in any location within the brain. Importantly, this treatment does not narrow down the spectrum of the possible subsequent salvage therapeutic options, since neither repeated interstitial nor additional external beam irradiation at the time of tumor progression after BT is associated with a significantly increased risk of radiogenic complications. Using correct patient selection criteria, appropriate surgical technique, and established treatment parameters, would make BT a truly minimally invasive procedure with a low risk of complications and reasonable efficacy.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000467114","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35786401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Pathology and Genetics of Gliomas. 神经胶质瘤的病理学和遗传学。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2018-01-25 DOI: 10.1159/000466835
Takashi Komori, Yoshihiro Muragaki, Mikhail F Chernov
{"title":"Pathology and Genetics of Gliomas.","authors":"Takashi Komori,&nbsp;Yoshihiro Muragaki,&nbsp;Mikhail F Chernov","doi":"10.1159/000466835","DOIUrl":"https://doi.org/10.1159/000466835","url":null,"abstract":"<p><p>Current World Health Organization (WHO) classification of the neuroepithelial tumors is cell lineage-oriented and based on a presumed developmental tree of the central nervous system (CNS). It defines three main groups of gliomas, namely astrocytomas, oligodendrogliomas, and ependymomas, and additionally presumes their 4-tiered histopathological grading (WHO grades I to IV). Nevertheless, the impact of tumor pathology on clinically related parameters may be frequently much better predicted by genetics, than by histological appearance of the lesion. Recent studies have revealed several major molecular alterations typical for different types of neoplasms, such as IDH1/IDH2 mutations in diffusely infiltrating gliomas, mutations of TP53 and ATRX in astrocytomas, 1p/19q co-deletion in oligodendrogliomas, mutations of TERT promoter in oligodendrogliomas and IDH wild-type glioblastomas, and mutations or fusions of BRAF in circumscribed astrocytomas, particularly in children. Identification of those and several other genetic abnormalities in the tumor is clinically important and may help clinicians to determine proper treatment strategy and to predict prognosis. Therefore, the updated WHO classification of CNS tumors (2016) considers not only phenotype, but also some genetic characteristics of gliomas.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000466835","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35786767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Chemotherapy of Intracranial Gliomas in Children. 儿童颅内胶质瘤的化疗。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2018-01-25 DOI: 10.1159/000467377
Keita Terashima
{"title":"Chemotherapy of Intracranial Gliomas in Children.","authors":"Keita Terashima","doi":"10.1159/000467377","DOIUrl":"https://doi.org/10.1159/000467377","url":null,"abstract":"<p><p>Under specific indications, chemotherapy may play an important role in the treatment of pediatric patients with intracranial gliomas. It can be effectively administered in inoperable low-grade tumors, particularly with the use of combination regimens based on carboplatin and vincristine. In very young children with high-grade gliomas (HGG), chemotherapy may result in control of tumor growth, which allows to postpone fractionated radiation therapy (FRT). At the same time, in difference with adults, there is no current evidence that addition of chemotherapy to aggressive surgical resection followed by FRT has any positive impact on survival of pediatric patients with non-pontine HGG. Similarly, chemotherapy is seemingly non-effective in the management of diffuse intrinsic pontine gliomas. Novel treatment strategies in such cases are desperately needed.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000467377","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35787736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Proton and Carbon Ion Therapy of Intracranial Gliomas. 脑胶质瘤的质子与碳离子治疗。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2018-07-10 DOI: 10.1159/000469680
Stephanie E Combs
{"title":"Proton and Carbon Ion Therapy of Intracranial Gliomas.","authors":"Stephanie E Combs","doi":"10.1159/000469680","DOIUrl":"https://doi.org/10.1159/000469680","url":null,"abstract":"<p><p>In comparison to photon irradiation, particle therapy of cancer performed either with protons or with carbon ions, offers the advantage of their distinct physical characteristics, and through delivery of high linear energy transfer (LET) particles, exploits greater relative biological effectiveness (RBE). There is strong rationale for applying such treatment in patients with intracranial gliomas. In cases of low-grade tumors, the main benefits may be related to potential decrease of long-term morbidity, whereas in cases of high-grade neoplasms, the use of modalities with greater RBE may lead to better tumor control and improve patient survival. Nevertheless, to date, there are no convincing data that confirm the superior effects of particle therapy (either with protons or carbon ions) in comparison to advanced photon fractionated radiotherapy (FRT) in patients with either newly diagnosed or recurrent intracranial gliomas. Therefore, the real clinical benefit of such treatment should be evaluated further in prospective clinical trials.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000469680","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36300198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Surgical Management of Recurrent Intracranial Gliomas. 复发性颅内胶质瘤的外科治疗。
Progress in neurological surgery Pub Date : 2018-01-01 Epub Date: 2017-12-14 DOI: 10.1159/000464438
Sherise D Ferguson, Eric N Momin, Jeffrey S Weinberg
{"title":"Surgical Management of Recurrent Intracranial Gliomas.","authors":"Sherise D Ferguson,&nbsp;Eric N Momin,&nbsp;Jeffrey S Weinberg","doi":"10.1159/000464438","DOIUrl":"https://doi.org/10.1159/000464438","url":null,"abstract":"<p><p>In cases of recurrent gliomas, the treatment options are limited and not yet standardized. Choices usually include re-operation, systemic chemotherapy, salvage re-irradiation, and supportive care, which can be used either separately or in combination. From a surgical perspective, management of recurrent brain tumor poses a significant challenge, as the desire to attain aggressive lesion resection must be balanced against the need to preserve neurological functions and to maximize the quality of life. Additionally, specific practical difficulties in performing repeat craniotomies and significant risk of perioperative morbidity in such cases necessitate careful selection of the optimal candidates for surgery.</p>","PeriodicalId":39342,"journal":{"name":"Progress in neurological surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000464438","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35656789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信